Gilgamesh is a clinical stage biotech developing novel medicines that harness the therapeutic promise of psychedelics to revolutionize the treatment of mental illness
Orally bioavailable
Rapid-acting
Fewer dissociative effects
Depression and other indications
New Chemical Entity
Hallucinogenic and non-halluncingenic
Optimized duration of effect
Improved cardiac safety profile
Depression and other indications
New Chemical Entities
Rapid and sustained efficacy
Improved cardiac safety profile
Opioid abuse disorder and other indications
New Chemical Entity
We collaborate with research institutions at the forefront of biotech innovation.